Quarterly Results of Operation

12 Months Ended

Dec. 31, 2011

Quarterly Results of Operation

Quarterly Results of Operation

(23) Quarterly Results of Operation (unaudited and restated)

The following is a summary of the unaudited quarterly results of operations:

2011
(in thousands except per share data)
	March 31, 2011			June 30, 2011			September 30, 2011			December 31, 2011			Total
Revenues	$	42		$	36		$	45		$	38		$	161
Costs and expenses		(3,632	)		(3,284	)		(3,602	)		(3,938	)		(14,456	)
Interest & other
Income (expense)		151			311			203			(82	)		583
Sales of tax NOL		2,272			0			0			0			2,272
Redeemable warrants
valuation adjustment		301			643			614			867			2,425
Net loss	$	(866	)	$	(2,294	)	$	(2,740	)	$	(3,115	)	$	(9,015	)
Basic and diluted loss per share	$	(.01	)	$	(.02	)	$	(.02	)	$	(.02	)	$	(.07	)

2010
(in thousands except per share data)
	March 31, 2010			June 30, 2010			September 30, 2010			December 31, 2010			Total
Revenues	$	32		$	41		$	35		$	27		$	135
Costs and expenses		(4,105	)		(3,810	)		(3,727	)		(4,880	)		(16,522	)
Interest & other
Income (expense)		29			93			438			1,812			2,372
Redeemable warrants
valuation adjustment		(1,336	)		2,260			(584	)		539			879
Net loss	$	(5,380	)	$	(1,416	)	$	(3,838	)	$	(2,502	)	$	(13,136	)
Basic and diluted loss per share	$	(.04	)	$	(.01	)	$	(.02	)	$	(.02	)	$	(.10	)

Hemispherx Biopharma, Inc.

Schedule II -Valuation and Qualifying Accounts

(dollars in thousands)

Description	Balance at beginning of period		Charge to expense		Write- offs			Balance at end of period
Year Ended December 31, 2009 Reserve for inventory	$	286	$	0	$	(4	)	$	282
Year Ended December 31, 2010 Reserve for inventory	$	282	$	0	$	(33	)	$	249
Year Ended December 31, 2011 Reserve for inventory	$	249	$	192	$	(249	)	$	192